IBO

Impact BioMedical Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-52.5K
ExitQ2 2025
$52k
--
$0.45

Insider Trades

NameValueActionPriceCurrent Price
Macko Todd DChief Financial Officer
$9611.6k shares
SellMar 25, 2026
$0.6008
$0.45
Macko Todd DChief Financial Officer
$24k43.4k shares
SellMar 27, 2026
$0.5615
$0.45
Grady JasonDirector
$33k50k shares
SellMar 23, 2026
$0.6501
$0.45
Dss, Inc.10 Percent Owner
$63k115.6k shares
SellMay 22, 2025
$0.5491
$0.45
Dss, Inc.10 Percent Owner
$25k45.4k shares
SellMay 27, 2025
$0.5403
$0.45
Dss, Inc.10 Percent Owner
$63k115.6k shares
SellMay 22, 2025
$0.5491
$0.45

News

businesswire.comImpact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBObusinesswire.comApr 12businesswire.comRosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBObusinesswire.comApr 11globenewswire.comImpact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plansglobenewswire.comApr 3